Is a complete FRA/5NRA research report available?

No complete published report is available for fra/5NRA (FRA/5NRA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/5NRA (FRA/5NRA)

Frankfurt Stock Exchange: FRA/5NRA · EUR

€33.2

+0.40 (+1.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/5NRA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.7B
Revenue (ttm)	32.6M
Net income (ttm)	-24M
EPS (ttm)	-€0.50
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 32.6M
Net income (ttm): -24M
EPS (ttm): -€0.50
Market cap: 1.7B

All FRA/5NRA indicators

Market & fundamental data

Available fields

155

Groups with data

Currency

EUR

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	DE
Employees	100
Employees Change	-8%
Employees Change Percent	-7.41
Enterprise value	EUR 1.8B
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 1.7B
Price	EUR 33.2
Price currency	EUR
Rev Per Employee	325,930x
Sic	2836
Symbol	fra/5NRA
Website	https://www.nanobiotix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.4%
EV/Sales	53.99x
FCF yield	-1.98%
P/B ratio	-20.33x
P/S ratio	52.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-33.39%
EBITDA Margin	-32.18%
Gross margin	100%
Gross Profit	EUR 32.6M
Gross Profit Growth3 Y	89.68%
Gross Profit Growth5 Y	69.57%
Net Income	EUR -24M
Pretax Margin	-73.51%
Profit Margin	-73.52%
Profit Per Employee	EUR -239,610
ROA	-10.06
Roa5y	-28.61
ROCE	-106.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	453.98%
Cagr3y	66.43%
Cagr5y	23.41%
Revenue Growth3 Y	89.68x
Revenue Growth5 Y	69.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.48
Assets	EUR 67.8M
Cash	EUR 52.8M
Current Assets	EUR 62.8M
Current Liabilities	EUR 57.5M
Debt	EUR 95.3M
Debt FCF	EUR -2.81
Equity	EUR -84.5M
Interest Coverage	-1.05
Liabilities	EUR 152.2M
Long Term Assets	EUR 5M
Long Term Liabilities	EUR 94.7M
Net Cash	EUR -42.6M
Net Cash By Market Cap	EUR -2.48
Tangible Book Value	EUR -84.5M
Tangible Book Value Per Share	EUR -1.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.09
Net Working Capital	EUR -43.2M
Quick ratio	1.05
Working Capital	EUR 5.2M
Working Capital Turnover	EUR 8.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	453.33%
200-day SMA	25.4
3Y total return	361.11%
50-day SMA	32.41
50-day SMA vs 200-day SMA	50over200
5Y total return	186.21%
All Time High	47.4
All Time High Change	-29.96%
All Time High Date	2026-05-15
All Time Low	2.44
All Time Low Change	1,260.66%
All Time Low Date	2024-12-06
ATR	1.71
Ch YTD	76.6
High	33.2
High52	47.4
High52 Date	2026-05-15
High52ch	-29.96%
Low	32.4
Low52	5.7
Low52 Date	2025-08-04
Low52ch	487.61%
Ma50ch	2.44%
Price vs 200-day SMA	30.71%
RSI	49.81
RSI Monthly	81.43
RSI Weekly	56.34
Sharpe ratio	2.12x
Sortino ratio	4.3
Total Return	-1.17%
Tr YTD	76.6
Tr1m	6.41%
Tr1w	-1.78%
Tr3m	16.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -10.9M
Operating margin	-33.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,347,707%
Net Borrowing	38,189,000
Shares Insiders	3.14%
Shares Institutions	13.6%
Shares Qo Q	1.69%
Shares Yo Y	1.17%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -37.5M
Adjusted OCF	-36,961,000
Average Volume	2.9x
Bv Per Share	-1.75
CAPEX	EUR -538,000
Ch1m	6.41
Ch1w	-1.78
Ch1y	453.3
Ch3m	16.08
Ch3y	361.1
Ch5y	186.2
Ch6m	84.44
Change	1.22%
Change From Open	1.84
Close	32.8
Days Gap	-0.61
Depreciation Amortization	393,000
Earnings Date	2026-09-18
EBIT	EUR -10.9M
EBITDA	EUR -10.5M
EPS	EUR -0.5
F Score	1
FCF	EUR -34M
FCF EV Yield	-1.93x
Financing CF	37,416,000
Fiscal Year End	December
Founded	2,003
Income Tax	EUR 3,000
Investing CF	-578,000
Is Primary Listing	0
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Ma150	27.65
Ma150ch	20.06%
Ma20	33.92
Ma20ch	-2.12%
Net CF	3,014,000
Next Earnings Date	2026-09-18
Open	32.6
Position In Range	100
Ppne	4,170,000
Price Date	2026-07-30
Relative Volume	20x
Revenue	32,593,000x
SBC By Revenue	10.86x
Share Based Comp	3,539,000
Tax By Revenue	0.01x
Tr6m	84.44%
Volume	0
Z Score	1.11

FRA/5NRA (FRA/5NRA)

Coverage state: Market snapshot only — no published research

Generate the first FRA/5NRA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/5NRA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/5NRA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/5NRA

Frequently asked questions